Literature DB >> 2291248

Prophylaxis in idiopathic calcium urolithiasis.

D Ackermann1.   

Abstract

The most important measure in the prophylaxis of idiopathic calcium urolithiasis is dietary advice. Patients should be kept to a high-fluid intake, increasing their diuresis by at least 0.51. The mineral content of drinking water seems to be of minor importance, but the liquid should be low in carbohydrates and oxalate. The intake of animal proteins should be reduced to no more than five meals with meat, fish or poultry per week. Excesses of oxalate-rich food must be avoided. The daily intake of calcium in dairy products should be in the range of 800-1200 mg. Sodium and refined carbohydrates should be moderately restricted. Medical treatment is indicated only in cases of recurrence under the appropriate diet. Selective treatment according to urinary chemical composition is favoured; alkali citrate, thiazides, allopurinol, and pyridoxine are of major interest.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2291248     DOI: 10.1007/bf00301526

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  31 in total

1.  Mild metabolic hyperoxaluria and its response to pyridoxine.

Authors:  H S Gill; G A Rose
Journal:  Urol Int       Date:  1986       Impact factor: 2.089

2.  Thiazides for patients with recurrent calcium stones: still an open question.

Authors:  D N Churchill; D W Taylor
Journal:  J Urol       Date:  1985-05       Impact factor: 7.450

3.  Are stone formers maladapted to refined carbohydrates?

Authors:  P N Rao; C Gordon; D Davies; N J Blacklock
Journal:  Br J Urol       Date:  1982-12

4.  Epidemiological risk factors in calcium stone disease.

Authors:  W G Robertson; M Peacock; P J Heyburn; F A Hanes
Journal:  Scand J Urol Nephrol Suppl       Date:  1980

5.  The pattern of urinary stone disease in Leeds and in the United Kingdom in relation to animal protein intake during the period 1960-1980.

Authors:  W G Robertson; M Peacock
Journal:  Urol Int       Date:  1982       Impact factor: 2.089

6.  Randomized trial of allopurinol in the prevention of calcium oxalate calculi.

Authors:  B Ettinger; A Tang; J T Citron; B Livermore; T Williams
Journal:  N Engl J Med       Date:  1986-11-27       Impact factor: 91.245

7.  Chlorthalidone reduces calcium oxalate calculous recurrence but magnesium hydroxide does not.

Authors:  B Ettinger; J T Citron; B Livermore; L I Dolman
Journal:  J Urol       Date:  1988-04       Impact factor: 7.450

8.  Treatment of recurrent calcium stone formation with cellulose phosphate.

Authors:  U Backman; B G Danielson; G Johansson; S Ljunghall; B Wikström
Journal:  J Urol       Date:  1980-01       Impact factor: 7.450

9.  Effect of high-calcium diet on urinary oxalate excretion in urinary stone formers.

Authors:  T Nakada; I Sasagawa; H Furuta; T Katayama; J Shimazaki
Journal:  Eur Urol       Date:  1988       Impact factor: 20.096

10.  The cause of idiopathic calcium stone disease: hypercalciuria or hyperoxaluria?

Authors:  W G Robertson; M Peacock
Journal:  Nephron       Date:  1980       Impact factor: 2.847

View more
  1 in total

Review 1.  Prospective therapeutic studies in nephrolithiasis.

Authors:  D K Ackermann
Journal:  World J Urol       Date:  1997       Impact factor: 4.226

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.